Ocular Therapeutix Stock Forecast - 20 Period Moving Average

OCUL Stock  USD 9.09  0.26  2.94%   
The 20 Period Moving Average forecasted value of Ocular Therapeutix on the next trading day is expected to be 9.94 with a mean absolute deviation of 0.93 and the sum of the absolute errors of 38.00. Ocular Stock Forecast is based on your current time horizon. Although Ocular Therapeutix's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Ocular Therapeutix's systematic risk associated with finding meaningful patterns of Ocular Therapeutix fundamentals over time.
  
At this time, Ocular Therapeutix's Payables Turnover is quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 3.37 this year, although the value of Inventory Turnover will most likely fall to 2.02. . The value of Common Stock Shares Outstanding is expected to slide to about 44.2 M. The value of Net Loss is expected to slide to about (67.1 M).
A commonly used 20-period moving average forecast model for Ocular Therapeutix is based on a synthetically constructed Ocular Therapeutixdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Ocular Therapeutix 20 Period Moving Average Price Forecast For the 27th of November

Given 90 days horizon, the 20 Period Moving Average forecasted value of Ocular Therapeutix on the next trading day is expected to be 9.94 with a mean absolute deviation of 0.93, mean absolute percentage error of 1.27, and the sum of the absolute errors of 38.00.
Please note that although there have been many attempts to predict Ocular Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ocular Therapeutix's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ocular Therapeutix Stock Forecast Pattern

Backtest Ocular TherapeutixOcular Therapeutix Price PredictionBuy or Sell Advice 

Ocular Therapeutix Forecasted Value

In the context of forecasting Ocular Therapeutix's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ocular Therapeutix's downside and upside margins for the forecasting period are 6.49 and 13.40, respectively. We have considered Ocular Therapeutix's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
9.09
9.94
Expected Value
13.40
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Ocular Therapeutix stock data series using in forecasting. Note that when a statistical model is used to represent Ocular Therapeutix stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria81.5932
BiasArithmetic mean of the errors -0.2022
MADMean absolute deviation0.9268
MAPEMean absolute percentage error0.0928
SAESum of the absolute errors37.997
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Ocular Therapeutix 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Ocular Therapeutix

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ocular Therapeutix. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocular Therapeutix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
5.629.0812.54
Details
Intrinsic
Valuation
LowRealHigh
7.0910.5514.01
Details
8 Analysts
Consensus
LowTargetHigh
11.9513.1314.57
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.26-0.25-0.23
Details

Other Forecasting Options for Ocular Therapeutix

For every potential investor in Ocular, whether a beginner or expert, Ocular Therapeutix's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ocular Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ocular. Basic forecasting techniques help filter out the noise by identifying Ocular Therapeutix's price trends.

Ocular Therapeutix Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ocular Therapeutix stock to make a market-neutral strategy. Peer analysis of Ocular Therapeutix could also be used in its relative valuation, which is a method of valuing Ocular Therapeutix by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ocular Therapeutix Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ocular Therapeutix's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ocular Therapeutix's current price.

Ocular Therapeutix Market Strength Events

Market strength indicators help investors to evaluate how Ocular Therapeutix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocular Therapeutix shares will generate the highest return on investment. By undertsting and applying Ocular Therapeutix stock market strength indicators, traders can identify Ocular Therapeutix entry and exit signals to maximize returns.

Ocular Therapeutix Risk Indicators

The analysis of Ocular Therapeutix's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ocular Therapeutix's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ocular stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Ocular Therapeutix is a strong investment it is important to analyze Ocular Therapeutix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocular Therapeutix's future performance. For an informed investment choice regarding Ocular Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Ocular Therapeutix to cross-verify your projections.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Revenue Per Share
0.529
Quarterly Revenue Growth
0.083
Return On Assets
(0.22)
Return On Equity
(0.73)
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.